Title
MD, PhD
Company
University Hospitals Leuven, Belgium
Bio
Eric Van Cutsem, MD, PhD, is since 2000 full professor at the University of Leuven. He is head of the division of Digestive Oncology at the University Hospitals Gasthuisberg Leuven (UZ Leuven) and University of Leuven (KUL) and is board member of the Leuven Cancer Institute (LKI). He is member of the Belgian Royal Academy of Medicine since 2015 and president of the Belgian Foundation Against Cancer since October 2016.
Professor Van Cutsem obtained his medical degree in 1983 from the University of Leuven,
specialized in internal medicine and gastroenterology and he was awarded his PhD in 1994. He has a mandate as clinical researcher of the Fund for Scientific Research (FWO) since 2003. Throughout his training he has spent several months in England, Switzerland, the USA and the Netherlands and he has been involved in clinical and research projects.
Eric Van Cutsem is a member of several scientific organizations. He is/was a member of the Scientific Program Committee and/or educational committee of ASCO, ASCO-GI cancers symposium, ESMO, UEG and ECCO. He served for ESMO as executive board member 2011-2013 and is since 2014 on the ESMO press committee. He was secretary from 2000 to 2003 and chair of the EORTC-GI group from 2003 to 2007 and is chairman of PETACC (Pan-European Trials on Adjuvant Colon Cancer) since 2008; he was board member of the EORTC 2009-2015 and president of European Society of Digestive Oncology (ESDO) and is co-chairman of the European Neuro-Endocrine Tumour Society (ENETS) registry.
He was chairman of the governmental colon cancer prevention task force in Flanders, Belgium and was president of BGDO (Belgian Group Digestive Oncology) 2010-2016 and is past-president since 2016. He was president of FAPA (Familial Adenomatous Polyposis Association) till 2016 and is now vice-president and is member of the general assembly of Kom tegen Kanker (Flemish Cancer Ligue). He is medical director of Europacolon (patient advocacy group).
He has been the founder (1999) of and is chair of the Scientific Committee of the ESMO GI/ World Congress on Gastrointestinal Cancer in Barcelona (in partnership with ESMO since 2005), the largest meeting on GI cancer with ± 3500 participants
specialized in internal medicine and gastroenterology and he was awarded his PhD in 1994. He has a mandate as clinical researcher of the Fund for Scientific Research (FWO) since 2003. Throughout his training he has spent several months in England, Switzerland, the USA and the Netherlands and he has been involved in clinical and research projects.
Eric Van Cutsem is a member of several scientific organizations. He is/was a member of the Scientific Program Committee and/or educational committee of ASCO, ASCO-GI cancers symposium, ESMO, UEG and ECCO. He served for ESMO as executive board member 2011-2013 and is since 2014 on the ESMO press committee. He was secretary from 2000 to 2003 and chair of the EORTC-GI group from 2003 to 2007 and is chairman of PETACC (Pan-European Trials on Adjuvant Colon Cancer) since 2008; he was board member of the EORTC 2009-2015 and president of European Society of Digestive Oncology (ESDO) and is co-chairman of the European Neuro-Endocrine Tumour Society (ENETS) registry.
He was chairman of the governmental colon cancer prevention task force in Flanders, Belgium and was president of BGDO (Belgian Group Digestive Oncology) 2010-2016 and is past-president since 2016. He was president of FAPA (Familial Adenomatous Polyposis Association) till 2016 and is now vice-president and is member of the general assembly of Kom tegen Kanker (Flemish Cancer Ligue). He is medical director of Europacolon (patient advocacy group).
He has been the founder (1999) of and is chair of the Scientific Committee of the ESMO GI/ World Congress on Gastrointestinal Cancer in Barcelona (in partnership with ESMO since 2005), the largest meeting on GI cancer with ± 3500 participants